Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook







Study examines how the body repairs myelin, which may help MS patients

13 December 2010

By Chris Chatterton

Appeared in BioNews 588

Preliminary findings from a new research study have helped give scientists a new insight into how the body naturally repairs myelin, the substance that insulates nerve cells in the brain.

The research conducted on rats identified the processes involved in the spontaneous 'remyelination' of cells. The scientists discovered that damaged rat cells sent out chemical messages that encouraged cells involved in the repair process - which were identified as primarily oligodendrocytes and macrophages - to leap into action.

The researchers also identified several genes that were involved and activated during the remyelination process, including the retinoid X receptor gamma gene. This was shown to stimulate stem cells - called oligodendrocyte precursor cells - to develop into fully-fledged oligodendrocytes. The scientists believe that a similar process occurs in human cells.

This work may therefore offer hope to people living with multiple sclerosis (MS), a progressive neurological disease that affects the central nervous system, which is estimated to affect 100,000 people in Britain and causes a wide range of symptoms. It occurs when the bodies own immune system attacks and destroys the 'myelin sheaths' that surround and protect the nerve cells.

Professor Robin Franklin from Cambridge University, who led the study, told the Guardian: 'Therapies that repair damage are the missing link in treating MS'. The Chief Executive of the Multiple Sclerosis Society described the research as 'one of the most exciting developments in recent years'.

But despite headlines such as 'Breakthrough could lead to MS drug' in the Independent, Professor Franklin remained cautious about the chances of a drug being developed. He told the Guardian: 'The caveat is that the road from where we are to a treatment is unpredictable, but at least we now have a road to go down'.

Scientists at the University of Cambridge carried out the work alongside colleagues at the Queen's Medical Research Institute in Edinburgh and other European and international academic organisations. The research was published in the journal Nature Neuroscience.

 

SOURCES & REFERENCES
Independent | 06 December 2010
 
Drugs hope to repair MS damage
Press Association | 07 December 2010
 
Guardian | 05 December 2010
 
NHS Choices | 06 December 2010
 
Financial Times | 05 December 2010
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

09 September 2013 - by Tamara Hirsch 
Genes involved in replenishing brain cells and their support materials are switched on during sleep, according to a study in mice... [Read More]
23 July 2012 - by Holly Rogers 
A genetic variation could explain why a previously promising class of drugs do not work as multiple sclerosis treatments despite being used successfully in other autoimmune diseases... [Read More]
15 August 2011 - by Dr Rebecca Hill 
Researchers have identified 29 new genetic variants with a link to multiple sclerosis (MS). This brings the total number of genetic changes associated with the disease, which affects around 2.5 million people worldwide, to nearly 50... [Read More]
01 August 2011 - by Dr Caroline Hirst 
UK scientists are launching a global clinical trial to test the potential and safety of stem cells to treat multiple sclerosis (MS)... [Read More]

02 August 2010 - by Marianne Neary 
Biotechnology company Geron has been given the all clear for the world's first clinical trial involving human embryonic stem cells (hESCs). This comes a year after the US Food and Drug Administration (FDA) placed the study on hold amid safety fears... [Read More]
10 May 2010 - by Dr Rachael Panizzo 
A clinical trial investigating the treatment of patients with multiple sclerosis (MS) using bone marrow stem cells has produced encouraging results, researchers at Bristol University have reported.... [Read More]
10 May 2010 - by Dr Nadeem Shaikh 
On 6th May 2010, the journal Nature Reviews Neurology published a new report about the future of multiple sclerosis (MS). The guidelines focus on the use of stem cell therapy. They were written by a group of international experts on the disease... [Read More]
04 May 2010 - by Dr Gabrielle Samuel 
Environmental factors, rather than genetics, may play a key role in multiple sclerosis (MS), according to new research published in Nature... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Good Fundraising Code

Advertise your products and services HERE - click for further details